# Altavo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/altavo

- Industry: Medical Devices & Equipment
- Headquarters: Dresden, Germany
- Website: www.altavo.eu/
- Total disclosed funding: $8.9M
- Latest round: Series A (Jan 12, 2026)
- Investors on record: 9

## About

Based in Dresden, Germany, and founded in 2021, Altavo GmbH operates as a medical device company that develops artificial voice using machine learning and sensor technology and offers services to people without voice. The company was Co-founded by its CEO Rudolf von Bünau and others. In December 2021, Altavo GmbH raised seed funding led by High-Tech Gründerfonds, Technologiegründerfonds Sachsen, Saxonia Systems, and TUDAG.

The firm offers artificial intelligence-based voice which uses sensor technology and machine learning technology to develop a medical device that helps people without voice and is also used in speech rehabilitation and in non-medical fields.

## Funding rounds

- Series A, Jan 12, 2026, $3.5M — High-Tech Gruenderfonds, Technologiegruenderfonds Sachsen, TUDAG, Bm-t, Novalis Biotech, SMERLION GmbH
- Series A, Feb 2, 2024, $5.4M — CFH Management, High-Tech Gruenderfonds, TUDAG, Bm-t, Saxonia Systems, Novalis Biotech, Occident Group, SMERLION GmbH
- Seed, Dec 1, 2021 — CFH Management, High-Tech Gruenderfonds, TUDAG, Saxonia Systems

## Investors

- CFH Management (https://capitalatlas.ai/funds/cfh-management) — Seed, Series A
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed, Series A
- TUDAG — Seed, Series A
- Saxonia Systems — Seed, Series A
- Bm-t (https://capitalatlas.ai/funds/bm-t) — Series A
- Novalis Biotech (https://capitalatlas.ai/funds/novalis-biotech) — Series A
- Occident Group — Series A
- SMERLION GmbH — Series A
- Technologiegruenderfonds Sachsen — Series A